4ZYI
Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with cpd2
Functional Information from GO Data
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 11 |
Details | binding site for residue 4TH A 201 |
Chain | Residue |
A | GLN24 |
A | TYR100 |
A | HOH319 |
A | LEU54 |
A | PHE55 |
A | MET62 |
A | TYR67 |
A | GLN72 |
A | PHE86 |
A | HIS96 |
A | ARG97 |
site_id | AC2 |
Number of Residues | 7 |
Details | binding site for residue CL A 202 |
Chain | Residue |
A | LYS64 |
A | LYS64 |
A | ASP80 |
A | ASP80 |
A | LEU81 |
A | LEU81 |
A | HOH325 |